Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
76.4M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
+$29.3M
-
Put/Call ratio
-
0.18
-
Number of buys
-
87
-
Number of sells
-
-70
-
Price
-
$18.66
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2023
196 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2023.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.4M shares
of 101M outstanding shares and own 75.64% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (14.1M shares), VANGUARD GROUP INC (8.83M shares), BlackRock Inc. (7.31M shares), STATE STREET CORP (4.08M shares), Point72 Asset Management, L.P. (3.43M shares), FIRST TRUST ADVISORS LP (2.72M shares), BAKER BROS. ADVISORS LP (2.64M shares), ARMISTICE CAPITAL, LLC (2.31M shares), GEODE CAPITAL MANAGEMENT, LLC (1.73M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.5M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.